StockData
Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc. (ALDX) stock

ALDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.69+0.02 (+3.63%)

Close on Nov 17, 2026Market cap $41.86MP/E –Yield –

Aldeyra Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Aldeyra Therapeutics

Aldeyra Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Aldeyra Therapeutics figures

See a number that looks wrong?